NewAmsterdam Pharma Company (NAMS)
NASDAQ:NAMS
Technical Sentiment
Overall Consensus
Buy
11Bullish
4Neutral
7Bearish
Technical Analysis Consensus
Neutral
3Bullish
4Neutral
3Bearish
Moving Average Consensus
Buy
8Bullish
0Neutral
4Bearish
NewAmsterdam Pharma Company’s (NAMS) Moving Averages Convergence Divergence (MACD) indicator is -0.59, suggesting NewAmsterdam Pharma Company is a Sell.
NewAmsterdam Pharma Company’s (NAMS) 20-Day exponential moving average is 30.85, while NewAmsterdam Pharma Company’s (NAMS) share price is $32.01, making it a Buy.
NewAmsterdam Pharma Company’s (NAMS) 50-Day exponential moving average is 32.04, while NewAmsterdam Pharma Company’s (NAMS) share price is $32.01, making it a Sell.
NewAmsterdam Pharma Company (NAMS) Pivot Points
Classic
27.13
28.10
28.72
29.69
30.30
31.27
31.89
Fibonacci
28.10
28.71
29.08
29.69
30.29
30.67
31.27
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.
NewAmsterdam Pharma Company (NAMS) Moving Averages
MA5
30.72Buy
30.69Buy
MA10
30.25Buy
30.52Buy
MA20
30.29Buy
30.85Buy
MA50
32.37Sell
32.04Sell
MA100
34.30Sell
32.26Sell
MA200
30.27Buy
28.87Buy
NewAmsterdam Pharma Company’s (NAMS) 10-Day exponential moving average is 30.52, while NewAmsterdam Pharma Company’s (NAMS) share price is $32.01, making it a Buy.
NewAmsterdam Pharma Company’s (NAMS) 100-Day exponential moving average is 32.26, while NewAmsterdam Pharma Company’s (NAMS) share price is $32.01, making it a Sell.
NewAmsterdam Pharma Company’s (NAMS) stock price is $32.01 and NewAmsterdam Pharma Company’s (NAMS) 50-day simple moving average is 32.37, creating a Sell signal.
NewAmsterdam Pharma Company’s (NAMS) stock price is $32.01 and NewAmsterdam Pharma Company’s (NAMS) 100-day simple moving average is 34.30, creating a Sell signal.
NewAmsterdam Pharma Company’s (NAMS) stock price is $32.01 and NewAmsterdam Pharma Company’s (NAMS) 200-day simple moving average is 30.27, creating a Buy signal.
NewAmsterdam Pharma Company (NAMS) Technical Indicators
RSI (14)
53.14
Neutral
STOCH (9,6)
47.28
Neutral
STOCHRSI (14)
51.35
Neutral
MACD (12,26)
-0.59
Sell
ADX (14)
14.21
Buy
Williams %R
-8.18
Sell
CCI (14)
125.46
Sell
ATR (14)
1.84
-
Ultimate Oscillator
50.71
Neutral
ROC
2.11
Buy
NewAmsterdam Pharma Company’s (NAMS) Relative Strength Index (RSI) is 53.14, creating a Neutral signal.
NewAmsterdam Pharma Company’s (NAMS) Trend Strength Indicator (ADX) is 14.21, creating a Buy signal.
NewAmsterdam Pharma Company’s (NAMS) Commodity Channel Index (CCI) is 125.46, creating a Sell signal.
NewAmsterdam Pharma Company’s (NAMS) Price Rate of Change (ROC) is 2.11, creating a Buy signal.
FAQ
Is NAMS a Buy, Hold, or Sell?
Based on NAMS’s technical indicators, NAMS is a Buy.
What is NAMS’s RSI (14)?
NAMS’s RSI (14) is 53.14, which suggests NAMS is a Neutral.
What is NAMS’s MACD?
NAMS’s MACD is -0.59, which suggests NAMS is a Sell.
What is NAMS’s 5-day moving average?
NAMS’s 5-day moving average is 30.72, which suggests NAMS is a Buy.
What is NAMS’s 20-day moving average?
NAMS 20-day moving average is 30.29, which suggests NAMS is a Buy.
What is NAMS’s 50-day moving average?
NAMS’s 50-day moving average is 32.37, which suggests NAMS is a Sell.
What is NAMS’s 200-day moving average?
NAMS’s 200-day moving average is 30.27, which suggests NAMS is a Buy.
What is NAMS’s Williams % R (14)?
NAMS’s Williams % R (14) is -8.18, which suggests NAMS is a Sell.
What is NAMS’s CCI (14)?
NAMS’s CCI (14) is 125.46, which suggests NAMS is a Sell.